150
Participants
Start Date
January 22, 2025
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
OnabotulinumtoxinA
Intramuscular Injections
Placebo
Intramuscular Injections
Hiroshima Station Clinic /ID# 268467, Hiroshima
Kotoni Tower Skin And Cosmetic Surgery Clinic /ID# 268460, Sapporo
Tokai University Hospital /ID# 268496, Isehara
Queen's Square Medical Center, Dermatology and Allergology /ID# 268454, Yokohama
Jun Clinic /ID# 268531, Nagano
Touyama Plastic Surgery Clinic /ID# 268456, Naha
Yoshikawa Skin Clinic /ID# 268494, Takatsuki
Tokyo Center Clinic /ID# 268477, Chuo-ku
Tokyo Asbo Clinic /ID# 268529, Chuo-ku
Ginza Skin Clinic /ID# 268532, Chuo-ku
Kitasato University Kitasato Institute Hospital /ID# 268499, Minato-ku
Forest Palace Dermatology Clinic /ID# 268599, Nerima-ku
Greenwood skin clinic Tachikawa /ID# 268528, Tachikawa-shi
Chiharu Dermatology Clinic Urawa /ID# 268497, Saitama
Akihabara Skin Clinic /ID# 268441, Tokyo
Lead Sponsor
AbbVie
INDUSTRY